Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review
Treatment with immune checkpoint inhibitors has revolutionized cancer treatment over the past several years. Despite their clinical benefits, a wide range of immune-mediated toxicities can be observed includin...
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Romy G. Younan, Roy A. Raad, Bassem Y. Sawan and Rabih Said Tags: Case Report Source Type: research
More News: Allergy | Allergy & Immunology | Anemia | Aplastic Anemia | Asthma | Cancer | Cancer & Oncology | Immunotherapy | Toxicology